Met Kinase Inhibitor

Alternative names

AUTS9, CADTK, CAK-beta, CAKB, CCNE, CCNE1_HUMAN, CDC28, CDC2A, CDK2_HUMAN, CDKN2, Calcium regulated non receptor proline rich tyrosine kinase, Calcium-dependent tyrosine kinase, Cell adhesion kinase beta, Cell devision kinase 2, Cell division protein kinase 2, Cyclin E1, Cyclin Es, Cyclin Et, Cyclin-dependent kinase 2, CyclinE, D249, E430023O05Rik, EC 2.7.10.2, FADK 2, FAK2_HUMAN, Focal adhesion kinase 2, G1/S specific cyclin E, G1/S-specific cyclin-E1, HGF receptor, HGF/SF receptor, HGFR, Hepatocyte growth factor receptor, MET proto oncogene, receptor tyrosine kinase, MET_HUMAN, MGC124628, MPF, Met proto oncogene tyrosine kinase, Met proto-oncogene, Met proto-oncogene (hepatocyte growth factor receptor), Oncogene MET, PKB, PTK, PTK2B, PTK2B protein tyrosine kinase 2 beta, PYK2, Proline-rich tyrosine kinase 2, Protein kinase B, Protein-tyrosine kinase 2-beta, Proto-oncogene c-Met, RAFTK, RAFTK2, RCCP2, Related adhesion focal tyrosine kinase, SF receptor, Scatter factor receptor, Tyrosine-protein kinase Met, c met, cdc2-related protein kinase, cyclin E variant ex5del, cyclin E variant ex7del, cyclin dependent kinase 2-alpha, kinase Cdc2, p33 protein kinase, p33(CDK2)